Literature DB >> 27126519

Persistent part-solid nodules with solid part of 5 mm or smaller: Can the 'follow-up and surgical resection after interval growth' policy have a negative effect on patient prognosis?

Jong Hyuk Lee1, Chang Min Park2,3, Hyungjin Kim1,4, Eui Jin Hwang1,5, Juil Park1, Jin Mo Goo1,6.   

Abstract

OBJECTIVE: To investigate whether "follow-up and surgical resection after interval growth" can negatively influence recurrence or mortality in patients with persistent part-solid nodules (PSNs) with solid components ≤5 mm.
METHODS: One hundred twenty five surgically resected persistent PSNs with solid components ≤5 mm in 125 individuals were evaluated. Of the 125 PSNs, 54 and 71 PSNs were categorized into interval growth and immediate surgery groups, respectively. Cox regression analysis was performed to evaluate the association of "follow-up until interval growth" with recurrence and survival, adjusted for initial clinical and CT features.
RESULTS: In the interval growth group, 30 patients showed increased nodule size, 10 increased solid parts, and the remaining 14 both patterns. Five patients showed clinical stage shifts (stage T1a, initially, to T1b after interval growth). Post-operative disease recurrence occurred in six individuals (interval growth group, n = 2/54; immediate surgery group, n = 4/71), and four individuals died (interval growth group, n = 1/54; immediate surgery group, n = 3/71). There were no significant differences between these two groups in terms of recurrence-free survival (p = 0.451) and overall survival (p = 0.185).
CONCLUSION: "Follow-up and surgical resection after interval growth" did not negatively influence the prognosis of patients with persistent PSNs with solid components ≤5 mm. KEY POINTS: • Incidences of post-operative recurrence or death in patients with PSN are low. • "Follow-up until interval growth" of PSNs does not negatively influence disease recurrence. • There was no survival disadvantage related with "follow-up until interval growth" in PSNs.

Entities:  

Keywords:  Follow-up studies; Lung adenocarcinoma; Mortality; Operation; Recurrence

Mesh:

Year:  2016        PMID: 27126519     DOI: 10.1007/s00330-016-4364-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

2.  Comparing smoothing techniques in Cox models for exposure-response relationships.

Authors:  Usha S Govindarajulu; Donna Spiegelman; Sally W Thurston; Bhaswati Ganguli; Ellen A Eisen
Journal:  Stat Med       Date:  2007-09-10       Impact factor: 2.373

Review 3.  Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.

Authors:  Hyungjin Kim; Chang Min Park; Jae Moon Koh; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

4.  The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity.

Authors:  Yoshihisa Kobayashi; Yukinori Sakao; Gautam A Deshpande; Takayuki Fukui; Tetsuya Mizuno; Hiroaki Kuroda; Noriaki Sakakura; Noriyasu Usami; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  Lung Cancer       Date:  2013-11-01       Impact factor: 5.705

5.  Volume and mass doubling times of persistent pulmonary subsolid nodules detected in patients without known malignancy.

Authors:  Yong Sub Song; Chang Min Park; Sang Joon Park; Sang Min Lee; Yoon Kyung Jeon; Jin Mo Goo
Journal:  Radiology       Date:  2014-06-14       Impact factor: 11.105

6.  Serum liver enzymes are associated with all-cause mortality in an elderly population.

Authors:  Edith M Koehler; Donatella Sanna; Bettina E Hansen; Frank J van Rooij; Jan Heeringa; Albert Hofman; Henning Tiemeier; Bruno H Stricker; Jeoffrey N L Schouten; Harry L A Janssen
Journal:  Liver Int       Date:  2013-11-13       Impact factor: 5.828

7.  Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society.

Authors:  David P Naidich; Alexander A Bankier; Heber MacMahon; Cornelia M Schaefer-Prokop; Massimo Pistolesi; Jin Mo Goo; Paolo Macchiarini; James D Crapo; Christian J Herold; John H Austin; William D Travis
Journal:  Radiology       Date:  2012-10-15       Impact factor: 11.105

8.  The long-term course of ground-glass opacities detected on thin-section computed tomography.

Authors:  Sei Won Lee; Cho-Sun Leem; Tae Jung Kim; Kyung Won Lee; Jin-Haeng Chung; Sanghoon Jheon; Jae-Ho Lee; Choon-Taek Lee
Journal:  Respir Med       Date:  2013-03-17       Impact factor: 3.415

9.  Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.

Authors:  Boksoon Chang; Jung Hye Hwang; Yoon-Ho Choi; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Ho Yun Lee; Kyung Soo Lee; Young Mog Shim; Joungho Han; Sang-Won Um
Journal:  Chest       Date:  2013-01       Impact factor: 9.410

10.  Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results.

Authors:  Hyun Ju Lee; Jin Mo Goo; Chang Hyun Lee; Chul-Gyu Yoo; Young Tae Kim; Jung-Gi Im
Journal:  Korean J Radiol       Date:  2007 Jan-Feb       Impact factor: 3.500

View more
  10 in total

1.  Persistent pulmonary subsolid nodules: How long should they be observed until clinically relevant growth occurs?

Authors:  Eui Jin Hwang; Chang Min Park
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

2.  Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management.

Authors:  Gianluca Milanese; Nicola Sverzellati; Ugo Pastorino; Mario Silva
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  Natural history of pathologically confirmed pulmonary subsolid nodules with deep learning-assisted nodule segmentation.

Authors:  Lin-Lin Qi; Jian-Wei Wang; Lin Yang; Yao Huang; Shi-Jun Zhao; Wei Tang; Yu-Jing Jin; Ze-Wei Zhang; Zhen Zhou; Yi-Zhou Yu; Yi-Zhou Wang; Ning Wu
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

4.  A simple prediction model using size measures for discrimination of invasive adenocarcinomas among incidental pulmonary subsolid nodules considered for resection.

Authors:  Hyungjin Kim; Jin Mo Goo; Chang Min Park
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

5.  Persistent pulmonary subsolid nodules with a solid component smaller than 6 mm: what do we know?

Authors:  Linlin Qi; Wenwen Lu; Ning Wu; Jianwei Wang
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

Review 6.  Management of Ground-Glass Nodules: When and How to Operate?

Authors:  Young Tae Kim
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

7.  Natural Progression of Ground-glass Nodules after Curative Resection for Non-small Cell Lung Cancer.

Authors:  Kanghoon Lee; Hyeong Ryul Kim; Seung-Il Park; Dong Kwan Kim; Yong-Hee Kim; Sehoon Choi; Geun Dong Lee
Journal:  J Korean Med Sci       Date:  2021-11-08       Impact factor: 2.153

8.  A radiomics nomogram for invasiveness prediction in lung adenocarcinoma manifesting as part-solid nodules with solid components smaller than 6 mm.

Authors:  Teng Zhang; Chengxiu Zhang; Yan Zhong; Yingli Sun; Haijie Wang; Hai Li; Guang Yang; Quan Zhu; Mei Yuan
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

9.  Differentiation of persistent pulmonary subsolid nodules with a solid component smaller than 6 mm: to be invasive adenocarcinoma or not to be?

Authors:  Jong Hyuk Lee; Chang Min Park
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

10.  Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.

Authors:  Hyae Young Kim; Kyu-Won Jung; Kun Young Lim; Soo-Hyun Lee; Jae Kwan Jun; Jeongseon Kim; Bin Hwangbo; Jin Soo Lee
Journal:  Cancer Res Treat       Date:  2017-07-17       Impact factor: 4.679

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.